283 related articles for article (PubMed ID: 35748543)
1. Research progress of the engagement of inorganic nanomaterials in cancer immunotherapy.
Peng T; Xu T; Liu X
Drug Deliv; 2022 Dec; 29(1):1914-1932. PubMed ID: 35748543
[TBL] [Abstract][Full Text] [Related]
2. Bioactive inorganic nanomaterials for cancer theranostics.
Pei Z; Lei H; Cheng L
Chem Soc Rev; 2023 Mar; 52(6):2031-2081. PubMed ID: 36633202
[TBL] [Abstract][Full Text] [Related]
3. Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.
Le QV; Suh J; Oh YK
AAPS J; 2019 May; 21(4):64. PubMed ID: 31102154
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
5. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy.
Chen Z; Yue Z; Yang K; Shen C; Cheng Z; Zhou X; Li S
Adv Healthc Mater; 2023 Oct; 12(26):e2300882. PubMed ID: 37539730
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
7. Nanomaterial-Based Drug Delivery Systems: A New Weapon for Cancer Immunotherapy.
Jiang Z; Zhang W; Zhang J; Liu T; Xing J; Zhang H; Tang D
Int J Nanomedicine; 2022; 17():4677-4696. PubMed ID: 36211025
[TBL] [Abstract][Full Text] [Related]
8. Tailoring inorganic nanoadjuvants towards next-generation vaccines.
Li X; Wang X; Ito A
Chem Soc Rev; 2018 Jul; 47(13):4954-4980. PubMed ID: 29911725
[TBL] [Abstract][Full Text] [Related]
9. Nanomaterials in tumor immunotherapy: new strategies and challenges.
Zhu X; Li S
Mol Cancer; 2023 Jun; 22(1):94. PubMed ID: 37312116
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in supramolecular peptide assemblies as virus mimics for cancer immunotherapy.
Cai Y; Ran W; Zhai Y; Wang J; Zheng C; Li Y; Zhang P
Biomater Sci; 2020 Feb; 8(4):1045-1057. PubMed ID: 31637384
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Vaccines for Cancer Immunotherapy.
Wang J; Mamuti M; Wang H
ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy.
Li SR; Huo FY; Wang HQ; Wang J; Xu C; Liu B; Bu LL
J Nanobiotechnology; 2022 Jun; 20(1):277. PubMed ID: 35701847
[TBL] [Abstract][Full Text] [Related]
13. Engineered nanomaterials for synergistic photo-immunotherapy.
Guo R; Wang S; Zhao L; Zong Q; Li T; Ling G; Zhang P
Biomaterials; 2022 Mar; 282():121425. PubMed ID: 35217344
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterials for cancer immunotherapy.
Song W; Musetti SN; Huang L
Biomaterials; 2017 Dec; 148():16-30. PubMed ID: 28961532
[TBL] [Abstract][Full Text] [Related]
15. Biomembrane nanostructures: Multifunctional platform to enhance tumor chemoimmunotherapy via effective drug delivery.
Jiang X; Wu L; Zhang M; Zhang T; Chen C; Wu Y; Yin C; Gao J
J Control Release; 2023 Sep; 361():510-533. PubMed ID: 37567505
[TBL] [Abstract][Full Text] [Related]
16. Nanomaterials: Breaking through the bottleneck of tumor immunotherapy.
Kang Y; Li S
Int J Biol Macromol; 2023 Mar; 230():123159. PubMed ID: 36610572
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional inorganic nanomaterials for cancer photoimmunotherapy.
Tang L; Zhang A; Zhang Z; Zhao Q; Li J; Mei Y; Yin Y; Wang W
Cancer Commun (Lond); 2022 Feb; 42(2):141-163. PubMed ID: 35001556
[TBL] [Abstract][Full Text] [Related]
18. Exploiting autophagy-regulative nanomaterials for activation of dendritic cells enables reinforced cancer immunotherapy.
Guan YH; Wang N; Deng ZW; Chen XG; Liu Y
Biomaterials; 2022 Mar; 282():121434. PubMed ID: 35202930
[TBL] [Abstract][Full Text] [Related]
19. Research progress of nanovaccine in anti-tumor immunotherapy.
Yao M; Liu X; Qian Z; Fan D; Sun X; Zhong L; Wu P
Front Oncol; 2023; 13():1211262. PubMed ID: 37692854
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterials with changeable physicochemical property for boosting cancer immunotherapy.
Ni Q; Xu F; Wang Y; Li Y; Qing G; Zhang Y; Zhong J; Li J; Liang XJ
J Control Release; 2022 Feb; 342():210-227. PubMed ID: 34998916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
